Perform Another (Advanced) Search

1.  Study Posting (1819) Trial #108315, Solid Tumors, Cincinnati, OH
...1819) Trial #108315, Solid Tumors, Cincinnati, OH Trial Information ADVL0612: A Phase I Study of Sunitinib (SU11248), an Oral Multi-Targeted Tyrosine Kinase Inhibitor, in Children with Refractory Solid Tumors What ...
...this study? The goals of this study are: • To find the highest safe dose of Sunitinib that can be given without causing severe side effects • To learn what kind of side ...
View Page

2.  Study Posting (1918) Trial #159917, Kidney Cancer, Savannah, GA
...Study Posting (1918) Trial #159917, Kidney Cancer, Savannah, GA Trial Information Sunitinib or Sorafenib in Treating Patients With Kidney Cancer That Was Removed By Surgery ECOG E2805 RATIONALE : Sunitinib and sorafenib may stop the growth of tumor cells by blocking some of the enzymes ...
View Page

3.  Study Posting (4167) Trial #136237, Metastatic Cancer, Gainesville, FL
...4167) Trial #136237, Metastatic Cancer, Gainesville, FL Trial Information A Randomized, Phase 2B Study of Sunitinib Plus Oxaliplatin, 5-FU, and Leucovorin (FOLFOX)versus Bevacizumab Plus FOLFOX as First-line Treatment ...
...Patients with Metastatic Colorectal Cancer Participants will be assigned to treatment with FOLFOX and either Sunitinib or Bevacizumab. Sunitinib will be provided free of charge. Patient Inclusion Criteria: measurable, metastatic disease ...
View Page

4.  Study Posting (797) Trial #141985, Renal Cell Carcinoma, Elgin, IL
...Study Posting (797) Trial #141985, Renal Cell Carcinoma, Elgin, IL Trial Information Adjuvant Sorafenib or Sunitinib for Unfavorable Renal Carcinoma The purpose of this study is to determine if either Sunitinib or Sorafenib can prevent recurrence of kidney cancer and to compare the effects (both good ...
View Page

5.  Study Posting (1918) Trial #159848, Lung Cancer, Savannah, GA
...Study Posting (1918) Trial #159848, Lung Cancer, Savannah, GA Trial Information Sunitinib, Cisplatin or Carboplatin, and Etoposide in Treating Patients With Extensive-Stage Small Cell Lung Cancer CALGB 30504 RATIONALE : Sunitinib may stop the growth of tumor cells by blocking some of the enzymes needed for ...
View Page

6.  Study Posting (1918) Trial #158907, Lung Cancer, Savannah, GA
...Study Posting (1918) Trial #158907, Lung Cancer, Savannah, GA Trial Information Sunitinib as Maintenance Therapy in Treating Patients With Stage III or Stage IV Non-Small Cell Lung Cancer Previously Treated With Combination Chemotherapy RATIONALE: Sunitinib may stop the growth of tumor cells by blocking some of the enzymes needed for ...
View Page

7.  Newly Approved Drug Therapies (893) Sutent (sunitinib), Pfizer,
...Newly Approved Drug Therapies (893) Sutent (sunitinib), Pfizer, Drug Information The following information is obtained from various newswires, published medical journal articles, and medical conference presentations. Drug Name: Sutent (sunitinib) Company: Pfizer Approval Status: Approved January 2006 Treatment Area: Kidney Cancer/Gastrointestinal Stromal Tumors General ...
View Page

8.  Study Posting (2917) Trial #154938, Renal Cell Carcinoma, Beech Grove, IN
...Renal Cell Carcinoma, Beech Grove, IN Trial Information Study VEG108844, a Study of Pazopanib Versus Sunitinib in the Treatment of Subjects With Locally Advanced and/or Metastatic Renal Cell Carcinoma Pazopanib Versus Sunitinib in the Treatment of Locally Advanced and/or Metastatic Renal Cell Carcinoma Patient Inclusion Criteria ...
View Page

9.  CenterWatch: Clinical Trials in Category (363) Renal Cell Carcinoma
...of Hope New! CTSU/ECOG E2805: A Randomized, Double-Blind Phase III Trial of Adjuvant Sunitinib versus Sorafenib versus Placebo in Patients with Resected Renal Cell Carcinoma Colorado Denver : The Urology ...
...an Immunotherapeautic in Subjects with Newly Diagnosed Advanced Stage Renal Cell Carcinoma in Combination with Sunitinib Georgia Atlanta : Emory University A Phase II Study Testing the Safety and Activity of AGS ...
View Page

10.  CenterWatch: New Medical Therapies in Disease Category (35), Pancreatic Cancer
...Gastroenterology • Oncology June 29, 2009 Pfizer reported positive results from a phase III trial of sunitinib for the treatment of pancreatic neuroendocrine tumors. This trial enrolled 154 subjects with progressive, well ...
...who had progressed in the last 12 months. The subjects were randomized to either the sunitinib (37.5 mg/day, continuous daily dosing) plus best supportive care or placebo plus best ...
View Page

11.  Study Posting (5432) Trial #157754, Sarcoma, Nashville, TN
...an oral HSP90 inhibitor, in patients with GIST refractory to, or intolerant of, imatinib and sunitinib. This study will examine the effect of BIIB021, an investigational oral HSP90 inhibitor, on FDG ...
...consent. • Pathologically confirmed GIST refractory to, intolerant of, or not a candidate for imatinib and sunitinib therapy. • FDG PET standard uptake value (SUVmax; averaged over a maximum of 5 lesions) greater ...
View Page

12.  Study Posting (5432) Trial #157752, Sarcoma, New York, NY
...an oral HSP90 inhibitor, in patients with GIST refractory to, or intolerant of, imatinib and sunitinib. This study will examine the effect of BIIB021, an investigational oral HSP90 inhibitor, on FDG ...
...consent. • Pathologically confirmed GIST refractory to, intolerant of, or not a candidate for imatinib and sunitinib therapy. • FDG PET standard uptake value (SUVmax; averaged over a maximum of 5 lesions) greater ...
View Page

13.  Study Posting (5432) Trial #157753, Sarcoma, Rochester, MN
...an oral HSP90 inhibitor, in patients with GIST refractory to, or intolerant of, imatinib and sunitinib. This study will examine the effect of BIIB021, an investigational oral HSP90 inhibitor, on FDG ...
...consent. • Pathologically confirmed GIST refractory to, intolerant of, or not a candidate for imatinib and sunitinib therapy. • FDG PET standard uptake value (SUVmax; averaged over a maximum of 5 lesions) greater ...
View Page

14.  Study Posting (5207) Trial #142172, Renal Cell Carcinoma, Dallas, TX
...an Immunotherapeautic in Subjects with Newly Diagnosed Advanced Stage Renal Cell Carcinoma in Combination with Sunitinib Purpose of Study The purpose of this study is to determine the effect that AGS-003 has on your type of cancer when given in combination with sunitinib. Kidney cell cancer that has not spread is potentially curable by surgery. After the disease ...
View Page

15.  Study Posting (5207) Trial #142167, Renal Cell Carcinoma, Lebanon, NH
...an Immunotherapeautic in Subjects with Newly Diagnosed Advanced Stage Renal Cell Carcinoma in Combination with Sunitinib Purpose of Study The purpose of this study is to determine the effect that AGS-003 has on your type of cancer when given in combination with sunitinib. Kidney cell cancer that has not spread is potentially curable by surgery. After the disease ...
View Page

16.  Study Posting (5207) Trial #142174, Renal Cell Carcinoma, Minneapolis, MN
...an Immunotherapeautic in Subjects with Newly Diagnosed Advanced Stage Renal Cell Carcinoma in Combination with Sunitinib Purpose of Study The purpose of this study is to determine the effect that AGS-003 has on your type of cancer when given in combination with sunitinib. Kidney cell cancer that has not spread is potentially curable by surgery. After the disease ...
View Page

17.  Study Posting (5207) Trial #142165, Renal Cell Carcinoma, Indianapolis, IN
...an Immunotherapeautic in Subjects with Newly Diagnosed Advanced Stage Renal Cell Carcinoma in Combination with Sunitinib Purpose of Study The purpose of this study is to determine the effect that AGS-003 has on your type of cancer when given in combination with sunitinib. Kidney cell cancer that has not spread is potentially curable by surgery. After the disease ...
View Page

18.  Study Posting (5207) Trial #142168, Renal Cell Carcinoma, Atlanta, GA
...an Immunotherapeautic in Subjects with Newly Diagnosed Advanced Stage Renal Cell Carcinoma in Combination with Sunitinib Purpose of Study The purpose of this study is to determine the effect that AGS-003 has on your type of cancer when given in combination with sunitinib. Kidney cell cancer that has not spread is potentially curable by surgery. After the disease ...
View Page

19.  Study Posting (5207) Trial #142171, Renal Cell Carcinoma, Denver, CO
...an Immunotherapeautic in Subjects with Newly Diagnosed Advanced Stage Renal Cell Carcinoma in Combination with Sunitinib Purpose of Study The purpose of this study is to determine the effect that AGS-003 has on your type of cancer when given in combination with sunitinib. Kidney cell cancer that has not spread is potentially curable by surgery. After the disease ...
View Page

20.  Study Posting (5207) Trial #141817, Renal Cell Cancer, Dallas, TX
...an Immunotherapeautic in Subjects with Newly Diagnosed Advanced Stage Renal Cell Carcinoma in Combination with Sunitinib Purpose of Study The purpose of this study is to determine the effect that AGS-003 has on your type of cancer when given in combination with sunitinib. Kidney cell cancer that has not spread is potentially curable by surgery. After the disease ...
View Page